Pediatric HIV drug gains FDA approval

05/6/2013 | Drug Store News

Bristol-Myers Squibb received federal approval of its Sustiva drug for children with HIV as young as 3 months. The approval allows the capsule to be opened and added to food or a beverage for patients who cannot swallow capsules or tablets.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC